Screener
Co-Diagnostics, Inc. CODX Q2 2026 earnings
Reported August 13, 2026 · After market close
Revenue$166.1KBeat by $33.6K
EPS-$1.46Beat by $1.54
Revenue estimate$132.6K
EPS estimate-$3.00
Next report
Nov 16, 2026 (in 3 months)Revenue estimate$169.0K
EPS estimate-$1.25
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Co-Diagnostics, Inc. report Q2 2026 earnings?
- Co-Diagnostics, Inc. (CODX) reported Q2 2026 earnings on August 13, 2026 after market close.
- What were Co-Diagnostics, Inc.'s Q2 2026 revenue and EPS?
- Co-Diagnostics, Inc. reported revenue of $166.1K and eps of $-1.46 for Q2 2026.
- Did Co-Diagnostics, Inc. beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $132.6K by $33.6K. EPS beat the consensus estimate of $-3.00 by $1.54.
- How did Co-Diagnostics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 2.0% from $162.9K a year earlier and eps declined 534.8% from $-0.23.
- Where can I find Co-Diagnostics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001493152-26-037739) and the 10-Q periodic report (0001493152-26-037762) directly on SEC EDGAR. The filing index links above go to sec.gov.
